文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The World Health Organization Prequalification Program and Clinical Pharmacology in 2030.

作者信息

Blaschke Terrence F, Lumpkin Murray, Hartman Daniel

机构信息

Stanford University, Stanford, California, USA.

Integrated Development, Bill & Melinda Gates Foundation, Seattle, Washington, USA.

出版信息

Clin Pharmacol Ther. 2020 Jan;107(1):68-71. doi: 10.1002/cpt.1680. Epub 2019 Nov 26.


DOI:10.1002/cpt.1680
PMID:31773722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7586841/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5144/7586841/55425dff29b3/CPT-107-68-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5144/7586841/3eb31e4c8fef/CPT-107-68-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5144/7586841/55425dff29b3/CPT-107-68-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5144/7586841/3eb31e4c8fef/CPT-107-68-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5144/7586841/55425dff29b3/CPT-107-68-g002.jpg

相似文献

[1]
The World Health Organization Prequalification Program and Clinical Pharmacology in 2030.

Clin Pharmacol Ther. 2020-1

[2]
The World Health Organization's prequalification program and its potential effect on data exclusivity laws.

Food Drug Law J. 2005

[3]
Sparks fly over patents and vital drugs at world health assembly.

Lancet. 2003-5-31

[4]
Are rich nations up for drug reform?

Nature. 2006-5-11

[5]
[On misery coast. Episode 1: the market of vital drugs].

Med Sci (Paris). 2003

[6]
Drug studies in developing countries.

Bull World Health Organ. 2001

[7]
[Patents and availability of essential drugs].

Med Clin (Barc). 2007-11-3

[8]
WHO and industry combine to form ethics body.

Nat Med. 2002-7

[9]
Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.

JAMA. 2017-2-7

[10]
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-third report.

World Health Organ Tech Rep Ser. 1993

引用本文的文献

[1]
Therapeutic Vaccines for Non-Communicable Diseases: Global Progress and China's Deployment Pathways.

Vaccines (Basel). 2025-8-20

[2]
Should Digital Interventions for HIV Self-Testing Be Regulated with World Health Organization Prequalification?

JMIR Mhealth Uhealth. 2025-8-22

[3]
From Target Product Profiles (TPPs) to Target Specimen Profiles (TSPs): A New Concept in Infectious Disease Biobanking for Diagnostic Applications.

Diagnostics (Basel). 2025-6-13

[4]
The evolution of HIV self-testing and the introduction of digital interventions to improve HIV self-testing.

Front Reprod Health. 2023-2-14

[5]
Bendiocarb and Malathion Resistance in Two Major Malaria Vector Populations in Cameroon Is Associated with High Frequency of the G119S Mutation (Ace-1) and Overexpression of Detoxification Genes.

Pathogens. 2022-7-23

[6]
Comparative study of the effect of solvents on the efficacy of neonicotinoid insecticides against malaria vector populations across Africa.

Infect Dis Poverty. 2022-4-25

[7]
COVID vaccination logistics: five steps to take now.

Nature. 2020-11

[8]
Research of Epidemic Big Data Based on Improved Deep Convolutional Neural Network.

Comput Math Methods Med. 2020

本文引用的文献

[1]
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.

Global Health. 2018-11-1

[2]
The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries.

BMC Med Educ. 2018-10-10

[3]
Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public Workshop.

Clin Pharmacol Ther. 2018-3-30

[4]
Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrations.

J Pharmacokinet Pharmacodyn. 2017-6

[5]
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.

PLoS One. 2016-11-16

[6]
Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.

Clin Pharmacol Ther. 2015-7-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索